Skip to content
  • Saturday, 12 September 2026
  • 6:32 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Contraline Secures $92.5 Million in Series B Funding to Advance Reversible Male Contraceptive to Late-Stage Clinical Trials
Pharmaceutical R&D

Contraline Secures $92.5 Million in Series B Funding to Advance Reversible Male Contraceptive to Late-Stage Clinical Trials

Teuku Ryan Jun 3, 2026 0

Contraline, a pioneering biotechnology firm backed by Google Ventures, has successfully closed a substantial $92.5 million Series B financing round.…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Develop Breakthrough Reversible Nonhormonal Male Contraceptive Through Targeted Meiotic Disruption

Dwi Wanna May 22, 2026 0

In a significant advancement for reproductive medicine, a team of researchers at Cornell University has announced a major breakthrough in…

Read More
Stem Cell & Regenerative Medicine

Cornell University Researchers Achieve Milestone in Developing Reversible Nonhormonal Male Contraceptive Targeting Meiosis

Dwi Wanna May 14, 2026 0

The pursuit of a reliable, reversible, and nonhormonal male contraceptive has long been described by the medical community as the…

Read More
Stem Cell & Regenerative Medicine

Discovery of Protein Interaction Regulating Sperm Morphogenesis Offers New Insights into Male Infertility and Contraceptive Development

Dwi Wanna May 14, 2026 0

The human biological system relies upon a sophisticated architecture of checks and balances to ensure the precise growth, maturation, and…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify Potential Pathway for Reversible Non-Hormonal Male Contraceptive Targeting Meiosis

Dwi Wanna May 7, 2026 0

Researchers at Cornell University have announced a significant breakthrough in reproductive science, successfully demonstrating a method for a safe, reversible,…

Read More
Stem Cell & Regenerative Medicine

Cornell University scientists develop a safe reversible and long-acting nonhormonal male contraceptive through targeted meiotic disruption

Dwi Wanna Apr 30, 2026 0

Researchers at Cornell University have announced a significant breakthrough in reproductive science, successfully demonstrating a method for nonhormonal male contraception…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Develop Safe and Reversible Nonhormonal Male Contraceptive Targeting the Meiosis Process

Dwi Wanna Apr 23, 2026 0

In a milestone for reproductive medicine, researchers at Cornell University have announced a significant breakthrough in the quest for a…

Read More
Stem Cell & Regenerative Medicine

Yale Led Research Uncovers Molecular Mechanism Blocking Fertilization Offering New Paths for Infertility and Contraceptive Science

Dwi Wanna Apr 22, 2026 0

In a landmark study that bridges four decades of biological mystery with cutting-edge structural chemistry, a research team led by…

Read More
Stem Cell & Regenerative Medicine

Yale Research Team Deciphers Molecular Mechanism Blocking Fertilization Paving the Way for New Contraceptive and Infertility Treatments

Dwi Wanna Apr 14, 2026 0

A multidisciplinary research team led by Yale University has successfully mapped the complex biological mechanisms that prevent sperm cells from…

Read More
Stem Cell & Regenerative Medicine

Yale Researchers Uncover Molecular Mechanism Preventing Fertilization Opening New Paths for Infertility and Contraceptive Science

Dwi Wanna Mar 21, 2026 0

In a landmark study that bridges the gap between molecular biophysics and reproductive medicine, a Yale-led research team has successfully…

Read More

Posts pagination

1 2
Hornworts Reveal a Novel Molecular Strategy to Enhance Photosynthetic Efficiency in PlantsThe Genetic Code’s Subtle Nuances: Researchers Uncover a Cellular Quality Control System for Codon EfficiencySartorius Unveils Groundbreaking Engineered CHO Cell Line Delivering Up to Three-Fold Productivity Boost for Biotherapeutic ManufacturingThe ‘Robust’ Data Scientist: Winning with Messy Data and Pingouin
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological LandscapeHarmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum InformationSolstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy PorustobartScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026
Advanced Materials Science
Harmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
Nila Kartika Wati Sep 12, 2026
Pharmaceutical R&D
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Teuku Ryan Sep 12, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ